Bushnell P J, Levin E D
Neurotoxicology Division, United States Environmental Protection Agency, Research Triangle Park, NC 27711.
Pharmacol Biochem Behav. 1993 Aug;45(4):765-76. doi: 10.1016/0091-3057(93)90119-e.
Changes in dopaminergic function have been associated with alterations in motor and cognitive function in man and in animals. This study was designed to assess the effects of dopaminergic drugs on these aspects of conditioned behavior in animals. Male Long-Evans rats were trained to perform an appetitive operant task that allowed daily quantification of working memory (accuracy of spatial delayed nonmatching-to-position), reference memory (accuracy of visual discrimination) and motor function [choice lever-press latency and nosepoke interresponse time (IRT) during delay]. The indirect dopamine agonist d-amphetamine (0.3-1.0 mg/kg) reduced nonmatching accuracy without significantly affecting discrimination accuracy, response latency, or nosepoke IRT. The D2/D3 agonist quinpirole (0.01-0.056 mg/kg) also decreased nonmatching accuracy without changing discrimination accuracy, but increased choice response latency and nosepoke IRT as well. The D1 agonist SKF 38393 (1.0-3.0 mg/kg) and the D1 antagonist SCH 23390 (0.01-0.03 mg/kg) only affected nosepoke IRT, at doses below those causing response failure. The D2 antagonist raclopride (0.056-0.177 mg/kg) exerted no significant effects at doses that did not suppress responding completely. The selective reduction of nonmatching accuracy by d-amphetamine and quinpirole indicates a mnemonic impairment specific to working memory (relative to reference memory). These results suggest further 1) that stimulation of D2/D3, but not D1, receptors may account for the d-amphetamine-induced deficit in working memory; 2) that stimulation of D2/D3 receptors alone by quinpirole may also impair spatial working memory, but only in conjunction with motor slowing; and 3) that antagonism of either receptor type (by SCH 23390 or raclopride) does not significantly affect memory at doses causing motor slowing and response failure.
多巴胺能功能的变化与人类和动物的运动及认知功能改变有关。本研究旨在评估多巴胺能药物对动物条件性行为这些方面的影响。雄性Long-Evans大鼠接受训练以执行一项食欲性操作任务,该任务允许每日量化工作记忆(空间延迟位置不匹配的准确性)、参考记忆(视觉辨别准确性)和运动功能[延迟期间选择杠杆按压潜伏期和鼻触反应间隔时间(IRT)]。间接多巴胺激动剂d-苯丙胺(0.3 - 1.0毫克/千克)降低了不匹配准确性,而对辨别准确性、反应潜伏期或鼻触IRT没有显著影响。D2/D3激动剂喹吡罗(0.01 - 0.056毫克/千克)也降低了不匹配准确性,同时不改变辨别准确性,但也增加了选择反应潜伏期和鼻触IRT。D1激动剂SKF 38393(1.0 - 3.0毫克/千克)和D1拮抗剂SCH 23390(0.01 - 0.03毫克/千克)仅在低于导致反应失败的剂量下影响鼻触IRT。D2拮抗剂雷氯必利(0.056 - 0.177毫克/千克)在未完全抑制反应的剂量下没有显著影响。d-苯丙胺和喹吡罗对不匹配准确性的选择性降低表明存在特定于工作记忆(相对于参考记忆)的记忆损伤。这些结果进一步表明:1)刺激D2/D3受体而非D1受体可能是d-苯丙胺引起工作记忆缺陷的原因;2)喹吡罗单独刺激D2/D3受体也可能损害空间工作记忆,但仅与运动减慢同时发生;3)在导致运动减慢和反应失败的剂量下,两种受体类型的拮抗剂(通过SCH 23390或雷氯必利)均不会显著影响记忆。